Insud Pharma
Antonella Volpe serves as the Global API Quality and Regulatory Director at Insud Pharma since January 2023, leading quality assurance, quality control, and regulatory strategy across API manufacturing sites and Joint Ventures. Volpe has been with Industriale Chimica s.r.l. Chemo Group since December 2001, holding the position of Quality Assurance and Regulatory Affairs Manager. Prior to this, Volpe worked in quality assurance at Dipharma from October 1989 to December 2001. Educational background includes studies at Ist. Magistrale Orsoline Saronno and Ist. Zanoni in Milano.
This person is not in any teams
This person is not in any offices
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.